Breast cancer missed at screening; hindsight or mistakes?

被引:7
作者
Hovda, Tone [1 ]
Larsen, Marthe [2 ]
Romundstad, Linda [3 ]
Sahlberg, Kristine Kleivi [4 ,5 ]
Hofvind, Solveig [2 ,6 ]
机构
[1] Vestre Viken Hosp Trust, Dept Radiol, POB 800, N-3004 Drammen, Norway
[2] Canc Registry Norway, Sect Breast Canc Screening, Oslo, Norway
[3] Vestre Viken Hosp Trust, Dept Radiol, Drammen, Norway
[4] Vestre Viken Hosp Trust, Dept Res & Innovat, Drammen, Norway
[5] Univ Oslo, Inst Clin Med, Fac Med, Oslo, Norway
[6] Arctic Univ Norway, Fac Hlth Sci, Dept Hlth & Care Sci, Tromso, Norway
关键词
Breast; Neoplasms; Mass screening; Mammography; Female; MAMMOGRAPHY; RISK;
D O I
10.1016/j.ejrad.2023.110913
中图分类号
R8 [特种医学]; R445 [影像诊断学];
学科分类号
1002 ; 100207 ; 1009 ;
摘要
Purpose: To investigate radiologists' interpretation scores of screening mammograms prior to diagnosis of screen -detected and interval breast cancers retrospectively classified as missed or true negative.Methods: We included data on radiologists' interpretation scores at screening prior to diagnosis for 1223 screen -detected and 1007 interval cancer cases classified as missed or true negative in an informed consensus-based review. All prior screening examinations were independently scored 1-5 by two radiologists; score 1 by both was considered concordant negative, score & GE; 2 by one radiologist discordant, and score & GE; 2 by both concordant positive. We analyzed associations between interpretation, review categories, mammographic features and his-topathological findings using descriptive statistics and logistic regression.Results: Among screen-detected cancers, 31% of missed and 10% of true negative cancers had discordant or concordant positive interpretation at prior screening. The corresponding percentages for interval cancer were 21% and 8%. Age-adjusted odds ratio (OR) and 95% confidence interval (CI) for missed screen-detected cancer was 3.8 (95% CI: 2.6-5.4) after discordant and 5.5 (95% CI: 3.2-9.5) after concordant positive interpretation, using concordant negative as reference. Corresponding ORs for missed interval cancer were 3.0 (95% CI: 2.0-4.5) for discordant and 6.3 (95% CI: 2.3-17.5) for concordant positive interpretation. Asymmetry was the dominating mammographic feature at prior screening for all, except concordant positive screen-detected cancers where a mass dominated. Histopathological characteristics did not vary statistically with interpretation.Conclusions: Most cancers were interpreted negatively at screening prior to diagnosis. Increased risk for missed screen-detected or interval cancer was observed after positive interpretation at prior screening.
引用
收藏
页数:6
相关论文
共 50 条
  • [21] Breast density assessment and organised breast cancer screening
    Bambara, Augustin Tozoula
    Ouedraogo, Nina-Astrid
    Ouedraogo, Pakisba Ali
    Benao, Ouattara Lydia Bamis
    Ouedraogo, Wilfried
    Savadogo, Leon Gueswende Blaise
    Ousseini, Diallo
    Rabiou, Cisse
    BULLETIN DU CANCER, 2023, 110 (09) : 903 - 911
  • [22] Women's Breast Cancer Screening Confidence by Screening Modality and Breast Density: A Breast Cancer Surveillance Consortium Survey Study
    Tosteson, Anna N. A.
    Schifferdecker, Karen E.
    Smith, Rebecca E.
    Wernli, Karen J.
    Zhao, Wenyan
    Kaplan, Celia P.
    Buist, Diana S. M.
    Henderson, Louise M.
    Sprague, Brian L.
    Onega, Tracy
    Budesky, Jill
    Jackson-Nefertiti, Gloria
    Johnson, Dianne
    Miglioretti, Diana L.
    Kerlikowske, Karla
    JOURNAL OF WOMENS HEALTH, 2022, 31 (11) : 1547 - 1556
  • [23] The Korean guideline for breast cancer screening
    Lee, Eun Hye
    Park, Boyoung
    Kim, Nam-Soon
    Seo, Hyun-Ju
    Ko, Kyoung Lan
    Min, Jun Won
    Shin, Myung-Hee
    Lee, Kiheon
    Lee, Seeyoun
    Choi, Nami
    Hur, Min Hee
    Kim, Dong Il
    Kim, Min Jung
    Kim, Sung Yong
    Sunwoo, Sung
    Dang, Ji Yeon
    Kim, Soo Young
    Kim, Yeol
    Lee, Won-Chul
    Jeong, Joon
    JOURNAL OF THE KOREAN MEDICAL ASSOCIATION, 2015, 58 (05): : 408 - 419
  • [24] Breast-Cancer Screening REPLY
    Warner, Ellen
    NEW ENGLAND JOURNAL OF MEDICINE, 2012, 366 (02) : 191 - 192
  • [25] Breast cancer screening: the questions answered
    Autier, Philippe
    Esserman, Laura J.
    Flowers, Chris I.
    Houssami, Nehmat
    NATURE REVIEWS CLINICAL ONCOLOGY, 2012, 9 (10) : 599 - 605
  • [26] Breast cancer screening in developing countries
    da Costa Vieira, Rene Aloisio
    Biller, Gabriele
    Uemura, Gilberto
    Ruiz, Carlos Alberto
    Curado, Maria Paula
    CLINICS, 2017, 72 (04) : 244 - 253
  • [27] Outcome of breast cancer screening in Denmark
    Lynge, Elsebeth
    Bak, Martin
    von Euler-Chelpin, My
    Kroman, Niels
    Lernevall, Anders
    Mogensen, Nikolaj Borg
    Schwartz, Walter
    Wronecki, Adam Jan
    Vejborg, Ilse
    BMC CANCER, 2017, 17
  • [28] Updated recommendations for breast cancer screening
    Gregory, Kimberly D.
    Sawaya, George F.
    CURRENT OPINION IN OBSTETRICS & GYNECOLOGY, 2010, 22 (06) : 498 - 505
  • [29] In the Clinic Breast Cancer Screening and Prevention
    Farkas, Amy H.
    Nattinger, Ann B.
    ANNALS OF INTERNAL MEDICINE, 2023, 176 (11) : ITC161 - ITC176
  • [30] The Great Breast Cancer Screening Conundrum
    Desai, Aakash
    Mathew, Aju
    INDIAN JOURNAL OF MEDICAL AND PAEDIATRIC ONCOLOGY, 2021, 42 (04) : 376 - 379